Dr. Jürgen Gerhardt founded the company as a spin-off from his dissertation.
As a genuine chemist, his first laboratory was situated in his own cellar. What was starting out small with production and sale of the AUTODERIVAT 100 and some analytical services for determination of enantiomeric purity, soon became a serious endeavour.
C.A.T. relocated to Hirschau close to the Swabian Alps.
A larger laboratory was established.
The first GC-MS was installed to determine enantiomeric purity highly accurately.
A first expansion was built to meet an ever growing demand for our analytical services.
A new method for determination of water in as little as 1 mg of solids was developed and quickly became one of our most sought after services.
Expanding even further within a short time.
C.A.T. received the accolade from the FDA by receiving our first GMP confirmation a few days after Heike joined the company. German authorities followed soon after in 2006.
Development of exceptional equipment has always been a staple at C.A.T and allows us to keep the competitive edge in the field of amino acid and peptide analysis.
The essence for our success has always been a strong team of competent coworkers which not only mastered routine analyses but were crucial during our second FDA inspection. At this time CAT more and more focused in analytical services of peptides.
Ion-Chromatography was introduced to supplement our analytical portfolio.
Dr. Heike Gerhardt was formally introduced as the managing director of C.A.T. Now, the whole family is working at C.A.T. - in true fashion of a family business.
Automation of peptides hydrolysis was developed and introduced to streamline sample preparation and increase recovery of challenging amino acids.
High resolution mass determination and peptide sequencing became possible after acquisition of our Bruker Impact II HR-ESI-MS.
Agilent’s OPENLAB was introduced as our primary and GMP-conform user interface.
Our third expansion doubled laboratory and office space.
As a biochemist with a strong background in automation and engineering, Dr. Martin Konnerth joined the company and fulfils diverse tasks from research and development to support in management.
A new method for preparation of formulated samples was developed and introduced - allowing for a vast improvement of repeatability and sample throughput.
Introduction of a “laoboratory information and management systems” (LIMS) ensures the highest standards in documentation and traceability.
We relaunch our vintage internet presence with a brand-new homepage improving on customer experience and accessibility to our service portfolio
…here’s to a bright and successful future
Dr. Heike Gerhardt is announced as CEO while Dr. Jürgen Gerhardt acts as senior advisor.
